BioSpace News Archive

Press Releases

Vima Therapeutics Announces First Dystonia Patient Dosed in Phase 2 Study and Extension of Series A to $100 Million to Advance Potential First-in-Class Oral Therapy for Dystonia and Parkinson’s Disease

March 11, 2026
·
4 min read
Press Releases

Kamada Declares Cash Dividend of $0.25 Per Share, to be Paid in Accordance with an Adopted Annual Cash Dividend Policy

March 11, 2026
·
5 min read
Press Releases

CRISPR Therapeutics Prices Upsized Convertible Senior Notes Offering

March 11, 2026
·
7 min read
Press Releases

GT Biopharma to Participate in the 38th Annual Roth Conference

March 11, 2026
·
2 min read
Press Releases

BIMZELX®▼(bimekizumab) superior to SKYRIZI® (risankizumab) in BE BOLD: first head-to-head study in active psoriatic arthritis (PsA) to demonstrate superiority in ACR50

March 11, 2026
·
17 min read
Press Releases

WHO Foundation and Novo Nordisk Expand Collaboration to Provide Financial Support towards strengthening health systems for Cardio-Renal-Metabolic Diseases

March 11, 2026
·
2 min read
Press Releases

Veristat Expands Regulatory and Clinical Services to Chinese Drug and Device Companies Seeking Efficient Way to Enter European Markets

March 11, 2026
·
4 min read
Press Releases

Precision BioSciences Receives U.S. Patent Allowances Covering the PBGENE-HBV Program

March 11, 2026
·
4 min read
Press Releases

Parabilis Medicines’ Zolucatetide, the First and Only Direct Inhibitor of the Elusive β-catenin:TCF Interaction, Receives FDA Orphan Drug Designation for the Treatment of Desmoid Tumors

March 11, 2026
·
6 min read
Press Releases

Aurion Biotech Appoints World Renowned Cornea Surgeon Marjan Farid, M.D., to Chair Medical Advisory Board

March 11, 2026
·
3 min read